Details der Publikation - Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

Medienart:	E-Artikel

Erscheinungsjahr:	2022
Erschienen:	2022

Enthalten in:	Zur Gesamtaufnahme - volume:20
Enthalten in:	BMC medicine - 20(2022), 1 vom: 08. Dez.

Sprache:	Englisch

Beteiligte Personen:	Kinoshita, Taku [VerfasserIn] Shinoda, Masahiro [VerfasserIn] Nishizaki, Yasuhiro [VerfasserIn] Shiraki, Katsuya [VerfasserIn] Hirai, Yuji [VerfasserIn] Kichikawa, Yoshiko [VerfasserIn] Tsushima, Kenji [VerfasserIn] Shinkai, Masaharu [VerfasserIn] Komura, Naoyuki [VerfasserIn] Yoshida, Kazuo [VerfasserIn] Kido, Yasutoshi [VerfasserIn] Kakeya, Hiroshi [VerfasserIn] Uemura, Naoto [VerfasserIn] Kadota, Junichi [VerfasserIn]

Links:	Volltext [kostenfrei]

Anmerkungen:	© The Author(s) 2022

doi:	10.1186/s12916-022-02695-5

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	OLC2133024417

Internformat


LEADER	01000naa a22002652 4500
001	OLC2133024417
003	DE-627
005	20230506094642.0
007	cr uuu---uuuuu
008	230506s2022 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1186/s12916-022-02695-5 \|2 doi
035			\|a (DE-627)OLC2133024417
035			\|a (DE-He213)s12916-022-02695-5-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 610 \|q VZ
100	1		\|a Kinoshita, Taku \|e verfasserin \|4 aut
245	1	0	\|a Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
264		1	\|c 2022
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © The Author(s) 2022
700	1		\|a Shinoda, Masahiro \|4 aut
700	1		\|a Nishizaki, Yasuhiro \|4 aut
700	1		\|a Shiraki, Katsuya \|4 aut
700	1		\|a Hirai, Yuji \|4 aut
700	1		\|a Kichikawa, Yoshiko \|4 aut
700	1		\|a Tsushima, Kenji \|4 aut
700	1		\|a Shinkai, Masaharu \|4 aut
700	1		\|a Komura, Naoyuki \|4 aut
700	1		\|a Yoshida, Kazuo \|4 aut
700	1		\|a Kido, Yasutoshi \|4 aut
700	1		\|a Kakeya, Hiroshi \|4 aut
700	1		\|a Uemura, Naoto \|4 aut
700	1		\|a Kadota, Junichi \|4 aut
773	0	8	\|i Enthalten in \|t BMC medicine \|d BioMed Central, 2003 \|g 20(2022), 1 vom: 08. Dez. \|h Online-Ressource \|w (DE-627)377271225 \|w (DE-600)2131669-7 \|w (DE-576)121906655 \|x 1741-7015 \|7 nnns
773	1	8	\|g volume:20 \|g year:2022 \|g number:1 \|g day:08 \|g month:12
856	4	0	\|u https://dx.doi.org/10.1186/s12916-022-02695-5 \|z kostenfrei \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_702
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2031
912			\|a GBV_ILN_2038
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2056
912			\|a GBV_ILN_2057
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2113
912			\|a GBV_ILN_2134
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_2446
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 20 \|j 2022 \|e 1 \|b 08 \|c 12

Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände